BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26642877)

  • 21. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
    Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.
    Nougaret S; Rouanet P; Molinari N; Pierredon MA; Bibeau F; Azria D; Lemanski C; Assenat E; Duffour J; Ychou M; Reinhold C; Gallix B
    Radiology; 2012 May; 263(2):409-18. PubMed ID: 22438364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix.
    Mayr NA; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Wen BC; Davis CS; Pelsang RE; Anderson B; Doornbos JF; Hussey DH; Yuh WT
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):915-24. PubMed ID: 8751400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.
    Mayr NA; Yuh WT; Taoka T; Wang JZ; Wu DH; Montebello JF; Meeks SL; Paulino AC; Magnotta VA; Adli M; Sorosky JI; Knopp MV; Buatti JM
    AJR Am J Roentgenol; 2006 Jul; 187(1):65-72. PubMed ID: 16794157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer.
    Soutter WP; Hanoch J; D'Arcy T; Dina R; McIndoe GA; DeSouza NM
    BJOG; 2004 Jul; 111(7):741-7. PubMed ID: 15198766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Skipar K; Hompland T; Lund KV; Lindemann K; Hellebust TP; Bruheim K; Lyng H
    Radiother Oncol; 2024 Jun; 195():110263. PubMed ID: 38556173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
    Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
    Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
    Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-scanner study of MRI radiomics in uterine cervical cancer: prediction of in-field tumor control after definitive radiotherapy based on a machine learning method including peritumoral regions.
    Takada A; Yokota H; Watanabe Nemoto M; Horikoshi T; Matsushima J; Uno T
    Jpn J Radiol; 2020 Mar; 38(3):265-273. PubMed ID: 31907716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.
    Curvo-Semedo L; Lambregts DM; Maas M; Thywissen T; Mehsen RT; Lammering G; Beets GL; Caseiro-Alves F; Beets-Tan RG
    Radiology; 2011 Sep; 260(3):734-43. PubMed ID: 21673229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted magnetic resonance imaging during radiotherapy of locally advanced cervical cancer--treatment response assessment using different segmentation methods.
    Haack S; Tanderup K; Kallehauge JF; Mohamed SM; Lindegaard JC; Pedersen EM; Jespersen SN
    Acta Oncol; 2015; 54(9):1535-42. PubMed ID: 26217984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct sagittal image registration and tumor delineation on sagittal magnetic resonance imaging sequences for image-guided brachytherapy of cervical cancer.
    Radawski JD; Huang Z; Wang JZ; Yuh WT; Mayr NA
    Discov Med; 2012 Jan; 13(68):47-56. PubMed ID: 22284783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
    Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
    J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Simpson DR; Scanderbeg DJ; Carmona R; McMurtrie RM; Einck J; Mell LK; McHale MT; Saenz CC; Plaxe SC; Harrison T; Mundt AJ; Yashar CM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):150-7. PubMed ID: 26130230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.
    Monguzzi L; Ippolito D; Bernasconi DP; Trattenero C; Galimberti S; Sironi S
    Eur J Radiol; 2013 Feb; 82(2):234-40. PubMed ID: 23122748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery.
    Gui B; Valentini AL; Miccò M; D'Agostino GR; Tagliaferri L; Zannoni GF; Fanfani F; Manfredi R; Bonomo L
    Acta Radiol; 2016 Sep; 57(9):1123-31. PubMed ID: 26622060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.